2 months ago
NUVB
AnalystsPriyanka GroverPriyanka Grover's Stock Forecasts
AnalystsPriyanka Grover
Sectors:
Industries:
Analyst Ranking
Bottom 6%
#5246 out of 5549 analysts
Average Return
-23.45%
Win Rate
24%4 out of 17
Risk vs Reward
Poor
Good
Priyanka Grover's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Recursion Pharmaceuticals IncRXRX | +22.54% | $3.46 | $4.24 | 2026-04-30 - 2026-10-29 | Strong Buy |
Neurogene IncNGNE | +8.75% | $26.50 | $28.82 | 2026-10-08 - 2026-10-29 | Strong Buy |
Rhythm Pharmaceuticals IncRYTM | +5.80% | $87.97 | $93.07 | 2026-10-15 - 2026-10-29 | Strong Buy |
Mereo Biopharma Group PLCMREO | +2.89% | $0.31 | $0.30 | 2026-08-19 - 2026-10-29 | Strong Sell |
Priyanka Grover Analyst Color
Get additional color on Priyanka Grover's coverage of popular stocks
Priyanka Grover's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals IncRYTM | 3 | Strong Buy | $145.00 | +55.80% | Maintains | 15 days ago |
Arcus Biosciences IncRCUS | 1 | Strong Buy | $41.00 | +120.31% | Initiates Coverage On | 16 days ago |
Neurogene IncNGNE | 1 | Strong Buy | $60.00 | +108.19% | Initiates Coverage On | 22 days ago |
Enliven Therapeutics IncELVN | 1 | Strong Buy | $75.00 | +66.37% | Initiates Coverage On | a month ago |
Kura Oncology IncKURA | 1 | Strong Buy | $30.00 | +184.09% | Initiates Coverage On | a month ago |
Bridgebio Oncology Therapeutics IncBBOT | 3 | Strong Buy | $23.00 | +751.85% | Maintains | 2 months ago |
Mereo Biopharma Group PLCMREO | 4 | Strong Sell | N/A | N/A | Downgrades | 2 months ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $13.00 | +172.54% | Initiates Coverage On | 2 months ago |
Relay Therapeutics IncRLAY | 2 | Strong Buy | $31.00 | +59.22% | Maintains | 3 months ago |
Recursion Pharmaceuticals IncRXRX | 1 | Strong Buy | $10.00 | +135.85% | Maintains | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.